Historical record - last NADAC effective date: 10/23/2019
Product Information
STAHIST AD TABLET is a brand product labeled by Magna Pharmaceuticals, Inc., priced at $0.5696 per EA under NDC 58407062530. Its NADAC has been published 360 times since Nov 28, 2013.
Strength
25; 60 mg/1; mg/1
Manufacturer
Magna Pharmaceuticals, Inc.NDC
58407062530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
10/23/2019
Active Ingredients
CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
12/20/2011
Pharmacological Classes
Price Statistics
The NADAC for STAHIST AD TABLET has been published 360 times since Nov 28, 2013, and over the history we have for it it has risen 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5696 per EA |
|---|---|
| All-time high | $0.5970 (Sep 11, 2019) |
| All-time low | $0.4487 (Nov 28, 2013) |
| Median price | $0.5358 |
| Average price | $0.5342 |
| Largest weekly change | -15.4% (Jul 23, 2014) |
| Weeks tracked | 360 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+27.0%
Last surveyed Oct 14, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Magna Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of STAHIST AD TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STAHIST AD TABLET, manufactured by Magna Pharmaceuticals, Inc., is $0.5696 per EA (NDC 58407062530), effective Oct 14, 2020.
How has the price of STAHIST AD TABLET changed over time?
Over the history we have for it, the NADAC for STAHIST AD TABLET has risen 27.0%. It has been tracked across 360 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for STAHIST AD TABLET?
Since Nov 28, 2013, the NADAC for STAHIST AD TABLET has ranged from a low of $0.4487 (Nov 28, 2013) to a high of $0.5970 (Sep 11, 2019), with a median of $0.5358 per EA.
Are there cheaper alternatives to STAHIST AD TABLET?
No other NADAC-published product currently shares the active ingredient and strength of STAHIST AD TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures STAHIST AD TABLET?
STAHIST AD TABLET (NDC 58407062530) is labeled by Magna Pharmaceuticals, Inc., and CMS classifies it as a brand product.